Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2000 of 3173 entries
View as:

Relative Bioavailability For Palbociclib Formulations

Phase: N/A Priority: Normal
NCT ID: NCT02083640 Org: User:
Start: 03/31/14 End: 05/31/14 Due: 05/31/15

Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00372567 Org: User:
Start: 06/30/07 End: 11/30/09 Due: 11/30/10

A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring

Phase: N/A Priority: Normal
NCT ID: NCT00646880 Org: User:
Start: 03/31/03 End: 08/31/03 Due: 08/31/04

Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan)

Phase: N/A Priority: Normal
NCT ID: NCT01470326 Org: User:
Start: 11/30/11 End: 06/30/16 Due: 06/30/17

A Study Of 4-1BB Agonist PF-05082566 Plus PD-1 Inhibitor MK-3475 In Patients With Solid Tumors (B1641003/KEYNOTE-0036)

Phase: N/A Priority: Normal
NCT ID: NCT02179918 Org: User:
Start: 08/31/14 End: 02/28/17 Due: 02/28/18

Study Of Single Ascending And Multiple Doses Of PF-04447943 In Japanese Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00959803 Org: User:
Start: 08/31/09 End: 11/30/09 Due: 11/30/10

CPG 7909 Injection in Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00070629 Org: User:
Start: 05/31/03 End: 07/31/07 Due: 07/31/08

Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)

Phase: N/A Priority: Normal
NCT ID: NCT00087490 Org: User:
Start: 10/31/04 End: 07/31/07 Due: 07/31/08

The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis

Phase: N/A Priority: Normal
NCT ID: NCT00056368 Org: User:
Start: 03/31/03 End: 10/31/04 Due: 10/31/05

A Study Comparing Amounts of Tafamidis In The Blood With Or Without Food

Phase: N/A Priority: Normal
NCT ID: NCT02534740 Org: User:
Start: 09/30/15 End: 12/31/15 Due: 12/31/16

A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00811018 Org: User:
Start: 03/31/03 End: 07/31/11 Due: 07/31/12

Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT03313037 Org: User:
Start: 10/10/17 End: 12/10/18 Due: 12/10/19

Complicated Skin and Skin Structure Infections

Phase: N/A Priority: Normal
NCT ID: NCT00619710 Org: User:
Start: 02/28/01 End: 04/30/04 Due: 04/30/05

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06977581 Org: User:
Start: 05/20/25 End: 08/15/27 Due: 08/15/28

Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Hemophilia A Patients

Phase: N/A Priority: Normal
NCT ID: NCT04396639 Org: User:
Start: 01/25/20 End: 09/24/20 Due: 09/24/21

EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04960202 Org: User:
Start: 07/16/21 End: 04/25/22 Due: 04/25/23

Dose Escalation Study of PF-07209326 in Healthy Participants and Participants With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT04255875 Org: User:
Start: 02/05/20 End: 07/07/23 Due: 07/07/24

Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT00409175 Org: User:
Start: 01/31/07 End: 05/31/09 Due: 05/31/10

Study of PF-04965842 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03806101 Org: User:
Start: 01/23/19 End: 04/11/19 Due: 04/11/20

Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy

Phase: N/A Priority: Normal
NCT ID: NCT01821118 Org: User:
Start: 06/30/13 End: 09/30/15 Due: 09/30/16

Acute Myeloid Leukemia Real World Treatment Patterns

Phase: N/A Priority: Normal
NCT ID: NCT04230564 Org: User:
Start: 10/31/20 End: 03/31/21 Due: 03/31/22

Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD.

Phase: N/A Priority: Normal
NCT ID: NCT03546400 Org: User:
Start: 09/25/18 End: 12/03/20 Due: 12/03/21

A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT02351856 Org: User:
Start: 02/02/15 End: 12/21/20 Due: 12/21/21

Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements

Phase: N/A Priority: Normal
NCT ID: NCT03760042 Org: User:
Start: 11/14/18 End: 04/15/19 Due: 04/15/20

A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00528619 Org: User:
Start: 11/30/06 End: 04/30/10 Due: 04/30/11